Lv3
372 积分 2021-06-03 加入
Treatment with activin type ii receptor antibody improves cardiac function in mice after myocardial infarction
5天前
已完结
ActRII takes centre stage in heart failure
16天前
已完结
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
28天前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
1个月前
已完结
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
1个月前
已完结
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial
2个月前
已完结
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
2个月前
已完结
A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers
2个月前
已完结
Long-term safety and tolerability of bimagrumab (BYM338) in sporadic inclusion body myositis
2个月前
已完结
Targeting ALK1 to block LDL transcytosis and halt atherosclerosis
2个月前
已完结
皖公网安备34019202002308
